Andersen, Mikael Rørdam

Laustsen, Andreas Hougaard

Lohse, Brian

Øhlenschlæger, Mia

Snakebite envenoming represents a major health threat intropical parts of the developing world1. Animal-derivedantisera currently constitute the only effective treatment option,but are associated with severe side effects due toincompatibility with the human immune system. We aim atdiscovering human antibodies that target the medically mostimportant toxins from N. melanoleuca venom using phagedisplay technology

Online Research Database In Technology

                       General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.  • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal   If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.     Downloaded from orbit.dtu.dk on: Dec 18, 2017Discovery of human antibodies against black cobra toxinsØhlenschlæger, Mia; Andersen, Mikael Rørdam; Lohse, Brian; Laustsen, Andreas HougaardPublication date:2016Document VersionPublisher's PDF, also known as Version of recordLink back to DTU OrbitCitation (APA):Øhlenschlæger, M., Andersen, M. R., Lohse, B., & Laustsen, A. H. (2016). Discovery of human antibodiesagainst black cobra toxins. Poster session presented at The Oxford Venoms Symposium 2016, Oxford, UnitedKingdom.Expression of soluble scFvs in E. coliToxin composition of N. melanoleuca venomSelection of high-affinity antibodies using       scFv displaying phagesAntibody-mixtures may protect against envenoming by targeting several toxinsNaja melanoleucaRecombinant antivenom – a new hope!Snakebite envenoming represents a major health threat intropical parts of the developing world1. Animal-derivedantisera currently constitute the only effective treatment option,but are associated with severe side effects due toincompatibility with the human immune system2. We aim atdiscovering human antibodies that target the medically mostimportant toxins from N. melanoleuca venom using phagedisplay technology.Discovery of human antibodies against black cobra toxins Mia Øhlenschlæger1,  Mikael R. Andersen1, Brian Lohse2, Andreas H. Laustsen1,21Department of Biotechnology and Biomedicine, Technical University of Denmark2Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of CopenhagenIgGs against black cobra neurotoxinsWe hope to discover human scFvs against medicallyimportant neurotoxins from N. melanoleuca. These may beconverted to human IgGs for prolonged protection againstsystemic neurotoxicity in human snakebite victims.This may help bring recombinant antivenoms with higherefficacy and fewer side effects to the market!123456[5]Contact informationmiaoehl@gmail.com / (+45) 30112038AcknowledgementsWe thank the Novo Nordisk Foundation for financial support (NNF16OC0019248)References[1] ] WHO fact sheet: http://www.who.int/mediacentre/factsheets/fs337/en/ [Accessed 30th of August 2016][2] Gutierrez JM, Leon G, Lomonte B, Angulo Y. (2011) Antivenoms for snakebite envenomings. In-flammation & Allergy-Drug Targets 10(5): 369-80. [3] Laustsen AH. (2016) Recombinant Antivenoms. University of Copenhagen.[4] Lauridsen LP, Laustsen AH, Lomonte B, Gutiérrez JM. (2016) Exploring the venom of the forest cobra; Toxicovenomics andantivenom profiling of the Naja melanoleuca snake, Submitted to Journal of Proteomics[5] Image found on http://pngimg.com/img/animals/snake [Accessed 30th of August 2016]3FTx, 57.1%PLA2, 12.9%SVMP, 9.7%CRISP, 7.6%KUN, 3.8%FMO,2.5%CELF,1.1%PDE,1.1%GPF,0.9%OHA,<0.5%NGF,<0.4%DRE,<0.3%SUSHI,<0.3%UNK,1.9%3FTx: Three-finger toxinsPLA2: Phospholipases A2SVMP : Snake venom metalloproteinasesCRISP: Cysteine-rich secretory proteinKUN : Bovine pancreatic trypsin inhibitors/Kunitz-type inhibitorsFMO: Flavin monoamine oxidasesCELF: Type-B carboxylesterases/lipasesPDE: PhosphodiesterasesGPF: Glutathione peroxidasesOHA: Ohanin/vesprynNGF: Nerve growth factorsDRE: DNA/RNA non specific_endonucleasesSUSHI: SelectinsUNK: Unknown proteins

Discovery of human antibodies against black cobra toxins

http://orbit.dtu.dk/ws/files/127391189/Discovery_of_human_antibodies_against_black_cobra_toxins.pdf

Discovery of human antibodies against black cobra toxins

Abstract

Similar works

Full text

Available Versions

Online Research Database In Technology